FDA inspection
Shandong Xinhua Pharmaceutical Co., Ltd. First Plant: FDA inspection ending Mar 31, 2016
FDA inspection 1000050 · No Action Indicated (NAI) · Zibo
Key facts
| Inspection ID | 1000050 |
|---|---|
| Firm | Shandong Xinhua Pharmaceutical Co., Ltd. First Plant |
| FEI number | 3002808153 |
| Address | 14 Dongyi Road, Zhangdian District |
| City | Zibo |
| Country | China |
| Fiscal year | 2016 |
| Inspection end date | Mar 31, 2016 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data